Effect of cerebrocrast on the function of human platelets and release of the arachidonic acid from plasma membrane

Cell Biochemistry and Function

Volumn 20, Issue 2, 2002, Pages 177-181

  Romano, L ^a   Sidoti, A ^a   De Luca, G ^a   Gugliotta, T ^a   Romano, P ^a   Scuteri, A ^a,b   Amato, A ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Arachidonic acid; Cerebrocrast; Intracellular calcium; Platelets; Thrombin

Indexed keywords

ARACHIDONIC ACID; CEREBROCRAST; GLUCOSE; ICOSANOID; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PHOSPHOLIPID; PROSTAGLANDIN E2; PROSTAGLANDIN G2; PROSTAGLANDIN H2; THROMBOXANE A2;

ARTICLE; CALCIUM CELL LEVEL; CARDIOVASCULAR DISEASE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; GLUCONEOGENESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; THROMBOGENESIS;

ARACHIDONIC ACID; BLOOD PLATELETS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CELL MEMBRANE; DIHYDROPYRIDINES; FURA-2; HUMANS;

EID: 0036091016     PISSN: 02636484     EISSN: None     Source Type: Journal    
DOI: 10.1002/cbf.944     Document Type: Article

References (49)

1. Cerebral ischemia: The role of thrombosis and of antithrombotic therapy
2. Thromboembolism and antithrombolic in cerebrovascular disease
3. Platelet hyperreactivity and prognosis in survivors of myocardial infarction
4. Antithrombic therapy in peripheral vascular disease
5. Cardiovascular disease and hypertension in diabetes mellitus
6. 2+ mobilization in platelet activation
7. Calcium as an intracellular messenger in blood platelets
8. 2+-dependent protein phosphorylation in platelet activation
9. Calcium regulation of platelet aggregation
10. Demonstration of the plasma membrane bound calcium pool in arachidonate stimulated platelets detected by chlortetracycline fluorescence
11. Establishment of microanalysis of prostaglandin metabolites by GC/MS and its clinical application
12. Release of prostaglandins and thromboxane into the coronary circulation in patients with ischemic heart disease
13. Mechanisms of alphathrombin, histamine and bradykinin induced endothelial permeability
14. Thrombin receptor expression in normal and atherosclerotic human arteries
15. Inhibitory analysis of LDL-induced aggregation of platelets
16. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo
17. Von Willebrand factor binding to platelet GP Iβ initiates signals for platelet activation
18. Expression of platelet glycoprotein (GP) V in heterologous cells and evidence for its association with GP I βα in forming a GP I β-IX-V complex on the cell surface
19. Glycoprotein V and Iβ-IX form a noncovalent complex in the platelet membrane
20. The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylylcyclase
21. Kinetic differences between thrombininduced and ADP-induced calcium influx and release from internal stores in fura-2 loaded human platelets
22. Arachidonate peroxidation and functions of human platelets
23. The physiological role for P450-derived arachidonic acid metabolites
24. Altered intraplatelet arachidonic acid metabolism in diabetic patients and its relation to arachidonic acid content in platelet phospholipids
25. 2 in allergic response and parturition
26. Molecular mechanisms of platelet activation
27. Platelets and thrombolytic therapy
28. Proteinase-activated receptors: New functions for old enzymes
29. Protease-activated receptor 3 is a second thrombin receptor in humans
30. A dual thrombin receptor system for platelet activation
31. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
32. Inositol cyclic triphosphate (inositol 1,2-(cyclic)-4,5-triphosphate) is formed upon thrombin stimulation of human platelets
33. The effect of cerebrocrast, a new 1,4-dihydropyridine derivative, on lipid and glucose metabolism in experimental diabetes
34. Normalizing effect of cerebrocrast, a new long-acting compound on glucose metabolism in normal and STZ-induced diabetic rats
35. 2+ channels in human platelets
36. Role of adenosine diphosphate in the aggregation of human blood platelets by thrombin and by fatty acids
37. Arachidonate release and phosphatidic acid turnover in stimulated human platelets
38. Calcium antagonistic drugs. Mechanism of action
39. Thrombin-induced calcium movements in platelet activation
40. The influence of CGP28392 a 1,4-dihydropyridine, on human platelet calcium and cyclic AMP metabolism
41. Calcium, calmodulin and protein kinase C dependence of platelet shape change
42. Dual mode of action of dihydropyridine calcium antagonists; a role for nitric oxide
43. Blocking of the receptor-stimulated calcium entry into human platelets by verapamil and nicardipine
44. Regulation of calcium mobilization and entry in human platelets by endothelium-derived factors
45. 2
46. Crosstalk among multiple signal-activated phospholipases
47. Thrombin signalling and protease-activated receptors
48. Activation of G12/G13 results in shape change and Rho/Rhokinase-mediated myosin light chain phosphorylation in mouse platelets
49. Activation of the β1 isozyme of phospholipase C by a subunit of the Gq class of G proteins